Thermo Fisher Scientific Financials

Market Capitalization $219.88 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	36.11
Forward PE	24.47
Price to Sales TTM	$5.19
Price to Book MRQ	$4.49
Enterprise to Revenue	5.87
Enterprise to EBITDA	23.52

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	14.48%
Operating Margin	18.06%
Return on Assets TTM	4.67%
Return on Equity TTM	12.94%

Income Statement

Revenue TTM	$42,369,998,848
Revenue per Share TTM	$110.63
Quarterly Revenue Growth	0.20%
Gross Profit TTM	$17,237,999,616
EBITDA	$11,735,000,000
Net Income to Common TTM	$6,135,000,064
Diluted EPS TTM	$15.92
Quarterly Earnings Growth YoY	-5.00%

Balance Sheet

Total Cash MRQ	$6,645,000,192
Total Cash per Share MRQ	$17.37
Total Debt MRQ	$
Total Debt to Equity MRQ	72.33
Current Ratio MRQ	1.63
Book Value per Share MRQ	$128.08

Cash Flow

Operating Cash Flow TTM	$9,100,000,256
Levered Free Cash Flow TTM	$6,782,374,912

TMO Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	382,500,000
Float Shares	381,654,939
Avg 10 Volume	2,172,130
Avg 30 Volume	None
Shares Short	3,520,153
Short Ratio	1.86
Short % of Shares	0.92%
% Held by Insiders	0.17%
% Held by Institutions	91.02%

Stock Price Summary

Beta	0.79
Fifty Two Week Low	$493.30
Fifty Two Week High	$627.88
Fifty Two Week Change	2.97%
Day 50 MA	$533.13
Day 200 MA	$570.11

Dividends and Splits

Forward Annual Dividend Rate	$1.56
Forward Annual Dividend Yield	0.27%
Trailing Annual Dividend Rate	$1.56
Trailing Annual Dividend Yield	0.27%
Payout Ratio	9.53%
Dividend Date	2025-01-15
Ex Dividend Date	2024-12-13
Last Split Factor
Last Split Date	1996-06-06